Lead hopping using SVM and 3D pharmacophore fingerprints.
The combination of 3D pharmacophore fingerprints and the support vector machine classification algorithm has been used to generate robust models that are able to classify compounds as active or inactive in a number of G-protein-coupled receptor assays. The models have been tested against progressively more challenging validation sets where steps are taken to ensure that compounds in the validation set are chemically and structurally distinct from the training set. In the most challenging example, we simulate a lead-hopping experiment by excluding an entire class of compounds (defined by a core substructure) from the training set. The left-out active compounds comprised approximately 40% of the actives. The model trained on the remaining compounds is able to recall 75% of the actives from the "new" lead series while correctly classifying >99% of the 5000 inactives included in the validation set.
Saeh
Jamal C
JC
Cancer Discovery, AstraZeneca R and D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA. jamal.saeh@astrazeneca.com
Lyne
Paul D
PD
Takasaki
Bryan K
BK
Cosgrove
David A
DA
D003198:Computer Simulation; D019992:Databases as Topic; D015259:Dopamine Agents / Q000737:chemistry* / Q000145:classification; D015195:Drug Design; D008956:Models, Chemical; D015233:Models, Statistical; D043562:Receptors, G-Protein-Coupled / Q000737:chemistry*
D015259:Dopamine Agents; D043562:Receptors, G-Protein-Coupled